🇺🇸 FDA
Patent

US 7763252

Methods for the treatment of cellular proliferative disorders

granted A61KA61K35/765A61K45/06

Quick answer

US patent 7763252 (Methods for the treatment of cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K35/765, A61K45/06, A61P, A61P35/00